查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2112224

增生性瘢痕和瘢痕疙瘩治療市場規模、佔有率和趨勢分析報告：按瘢痕類型、產品類型、最終用途、地區和細分市場預測（2026-2033 年）

Hypertrophic And Keloid Scar Treatment Market Size, Share & Trends Analysis Report By Scar Type, By Product, By End-use (Business to Business, Business to Consumers ), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

增生性瘢痕和瘢痕疙瘩治療市場概述

預計到 2025 年，全球肥厚性瘢痕和瘢痕疙瘩治療市場價值將達到 7.632 億美元，到 2026 年將成長至 8.427 億美元，到 2033 年將擴大至 16.802 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 10.4%。

到2025年，亞太地區將佔據最大的市場佔有率，達到46.1%。除了交通事故和燒燙傷病例數量的增加外，技術進步和人們對整形手術的日益了解也是近年來推動該行業成長的主要因素。

全球交通事故和燒燙傷事件的增加預計將推動增生性瘢痕和瘢痕疙瘩治療市場的發展。例如，根據國際道路安全旅行協會（Association for Safe International Road Travel）統計，每年約有135萬人死於交通事故。此外，根據同一資訊來源統計，美國每年有440萬人遭受嚴重傷害。痤瘡及其長期併發症在全球日益嚴重的負擔是增生性瘢痕和瘢痕疙瘩治療產業成長的主要促進因素。 2024年2月，皮爾法伯實驗室（Pierre Fabre Laboratories）在《美國皮膚病學會雜誌》（JAAD）上發表了一項突破性的全球流行病學研究，該研究是ALL-Project舉措的一部分。這項大規模研究調查了20個國家的50,552名成年人，涵蓋了全球超過50%的人口，是對痤瘡盛行率及其社會影響最全面的評估之一。

根據這項研究，全球痤瘡盛行率為20.5%，這意味著全球五分之一的人患有痤瘡。青少年和青年（16-24歲）的盛行率最高，達28.3%，25-39歲成年人的盛行率也高達19.3%。女性比男性更容易受到影響（23.6% vs. 17.5%），而且，痤瘡疤痕和色素沉著治療的長期消費群體正在不斷擴大。

從區域來看，拉丁美洲（23.9%）、東亞（20.2%）、非洲（18.5%）和中東（16.1%）的盛行率最高，而歐洲（9.7%）和澳洲（10.8%）的盛行率較低。許多高盛行率地區與易患發炎後色素沉著和增生性瘢痕的人群重疊，這推動了對靶向局部治療的需求。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：增生性疤痕和瘢痕疙瘩治療市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 治療增生性瘢痕和瘢痕疙瘩的市場分析工具

第4章：增生性瘢痕和瘢痕疙瘩治療市場：按瘢痕類型分類的估算和趨勢分析

  • 增生性瘢痕和瘢痕疙瘩治療市場：按瘢痕類型分類的波動分析
  • 增生性瘢痕和瘢痕疙瘩治療市場：按瘢痕類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 增生性瘢痕
  • 瘢痕疙瘩

第5章：增生性瘢痕和瘢痕疙瘩治療市場：按產品分類的估算和趨勢分析

  • 增生性瘢痕和瘢痕疙瘩治療市場：基於應用領域的波動分析
  • 增生性瘢痕和瘢痕疙瘩治療市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 外用製劑
    • 矽膠片
    • 奶油
    • 凝膠
    • 其他
  • 雷射產品
    • 脈衝染料雷射
    • 二氧化碳雷射
    • 其他
  • 注射劑

第6章：增生性疤痕和瘢痕疙瘩治療市場：依最終用途分類的估算與趨勢分析

  • 增生性瘢痕和瘢痕疙瘩治療市場：按最終用途分類的波動分析
  • 增生性瘢痕和瘢痕疙瘩治療市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 企業對企業 (B2B) 交易
    • 醫院
    • 診所
  • B2C（企業對消費者）
    • 藥局
    • 線上電子商務
    • 大賣場和超級市場
    • 其他

第7章：增生性疤痕和瘢痕疙瘩治療市場：區域估算和趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • Smith & Nephew
    • Merz Pharmaceuticals, LLC
    • Sonoma Pharmaceuticals, Inc.
    • CCA Industries, Inc.
    • Newmedical Technology Inc.
    • Molnlycke Health Care AB
    • Perrigo Company plc
    • Rejuvaskin/Scar Heal Inc.
    • Alliance Pharma PLC
    • Hanson Medical, Inc.
    • Lumenis Be Ltd.
    • CYNOSURE
Product Code: GVR-2-68038-654-7

Hypertrophic And Keloid Scar Treatment Market Summary

The global hypertrophic and keloid scar treatment market size was valued at USD 763.2 million in 2025 and is projected to grow from USD 842.7 million in 2026 to USD 1,680.2 million by 2033, at a CAGR of 10.4% from 2026 to 2033. Asia Pacific held the largest market share of 46.1% in 2025. The increase in the number of road accidents & burn cases, along with technological advancements and growing awareness regarding the availability of aesthetic surgery, are major factors boosting the industry adoption over the years.

The global increase in the number of road accidents & burn incidence is anticipated to boost the hypertrophic and keloid scar treatment industry. For instance, according to the Association for Safe International Road Travel, approximately 1.35 million people die in road accidents every year. Moreover, as per a similar source, in the U.S., 4.4 million people get seriously injured. The increasing global burden of acne and its long-term secondary effects are key drivers of growth in the hypertrophic and keloid scars industry. In February 2024, a landmark global epidemiology study was published in the Journal of the American Academy of Dermatology (JAAD) by Pierre Fabre Laboratories as part of the ALL-project initiative. This large-scale study surveyed 50,552 adults across 20 countries, representing over 50% of the world's population, making it one of the most comprehensive assessments of acne prevalence and its societal impact.

The study found that global acne prevalence stands at 20.5%, meaning one in five individuals worldwide is affected. Prevalence is highest among adolescents and young adults (16-24 years) at 28.3% and remains high in adults aged 25-39 years at 19.3%. Women are more affected than men (23.6% vs. 17.5%), broadening the long-term consumer base for post-acne scar and pigmentation treatments.

Geographically, the highest prevalence rates were observed in Latin America (23.9%), East Asia (20.2%), Africa (18.5%), and the Middle East (16.1%), while Europe (9.7%) and Australia (10.8%) reported lower rates. Many high-prevalence regions overlap with populations predisposed to PIH and hypertrophic scarring, strengthening demand for targeted topical therapies.

Global Hypertrophic And Keloid Scar Treatment Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the hypertrophic and keloid scar treatment market report based on scar type, product, end use, and region:

  • Scar type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hypertrophic Scar
  • Keloid Scar
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Topical Products
    • Silicone Sheets
    • Creams
    • Gels
    • Others
  • Laser Products
    • Pulsed Dye Lasers
    • CO2 Lasers
    • Others
  • Injectables
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Business to Business (B2B)
    • Hospitals
    • Clinics
  • Business to Consumers (B2C)
    • Pharmacies
    • Online/E-commerce
    • Hypermarkets &Supermarkets
    • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Scar Type
    • 1.2.2. Product
    • 1.2.3. End Use
    • 1.2.4. Region scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Scar type outlook
    • 2.2.2. Product outlook
    • 2.2.3. End use outlook
    • 2.2.4. Region outlook
  • 2.3. Competitive Insights

Chapter 3. Hypertrophic & Keloid Scar Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Hypertrophic & Keloid Scar Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Hypertrophic & Keloid Scar Treatment Market: Scar Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hypertrophic & Keloid Scar Treatment Market: Scar Type Movement Analysis
  • 4.3. Hypertrophic & Keloid Scar Treatment Market by Scar Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Hypertrophic Scar
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Keloid Scar
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hypertrophic & Keloid Scar Treatment Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hypertrophic & Keloid Scar Treatment Market: Application Movement Analysis
  • 5.3. Hypertrophic & Keloid Scar Treatment Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Topical Products
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Silicone Sheets
      • 5.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Creams
      • 5.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Gels
      • 5.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Laser Products
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Pulsed Dye Lasers
      • 5.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. CO2 Lasers
      • 5.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4. Others
      • 5.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Injectables
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hypertrophic & Keloid Scar Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Hypertrophic & Keloid Scar Treatment Market: End Use Movement Analysis
  • 6.3. Hypertrophic & Keloid Scar Treatment Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Business to Business (B2B)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Hospitals
      • 6.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Clinics
      • 6.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Business to Consumers (B2C)
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Pharmacies
      • 6.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Online/E-commerce
      • 6.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. Hypermarkets &Supermarkets
      • 6.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Others
      • 6.6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Hypertrophic & Keloid Scar Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Denmark
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Norway
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Smith & Nephew
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Merz Pharmaceuticals, LLC
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Sonoma Pharmaceuticals, Inc.
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. CCA Industries, Inc.
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Newmedical Technology Inc.
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Molnlycke Health Care AB
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Perrigo Company plc
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Rejuvaskin/ Scar Heal Inc.
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Alliance Pharma PLC
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Hanson Medical, Inc.
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Lumenis Be Ltd.
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. CYNOSURE
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 5 North America hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 6 North America hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 7 U.S. hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 8 U.S. hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 9 U.S. hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 10 Canada hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 11 Canada hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 13 Mexico hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 14 Mexico hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 15 Mexico hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 16 Europe hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 18 Europe hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 19 Europe hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 20 UK hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 21 UK hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 22 UK hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 23 Germany hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 24 Germany hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 25 Germany hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 26 France hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 27 France hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 28 France hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 29 Italy hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 30 Italy hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 31 Italy hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 32 Spain hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 33 Spain hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 34 Spain hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 35 Denmark hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 36 Denmark hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 37 Denmark hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 38 Sweden hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 39 Sweden hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 40 Sweden hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Norway hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 42 Norway hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 43 Norway hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 48 Japan hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 49 Japan hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 50 Japan hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 51 China hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 52 China hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 53 China hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 54 India hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 55 India hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 56 India hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 57 Australia hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 58 Australia hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 59 Australia hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 60 South Korea hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 61 South Korea hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 62 South Korea hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 63 Thailand hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 64 Thailand hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 65 Thailand hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Latin America hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 68 Latin America hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 69 Latin America hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 70 Brazil hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 71 Brazil hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 72 Brazil hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 73 Argentina hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 74 Argentina hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 75 Argentina hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 76 Middle East & Africa hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
  • Table 77 Middle East & Africa hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 78 Middle East & Africa hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 80 South Africa hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 81 South Africa hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 82 South Africa hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 86 UAE hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 87 UAE hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 88 UAE hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
  • Table 89 Kuwait hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
  • Table 90 Kuwait hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
  • Table 91 Kuwait hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hypertrophic & keloid scar treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Scar type and product outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Hypertrophic & keloid scar treatment market dynamics
  • Fig. 13 Hypertrophic & keloid scar treatment market: Porter's five forces analysis
  • Fig. 14 Hypertrophic & keloid scar treatment market: PESTLE analysis
  • Fig. 15 Hypertrophic & keloid scar treatment market: Scar type segment dashboard
  • Fig. 16 Hypertrophic & keloid scar treatment market: Scar type market share analysis, 2025 & 2033
  • Fig. 17 Hypertrophic scar treatment market, 2021 - 2033 (USD Million)
  • Fig. 18 Keloid scar market, 2021 - 2033 (USD Million)
  • Fig. 19 Hypertrophic & keloid scar treatment market: Product segment dashboard
  • Fig. 20 Hypertrophic & keloid scar treatment market: Product market share analysis, 2025 & 2033
  • Fig. 21 Topical products market, 2021 - 2033 (USD Million)
  • Fig. 22 Silicone sheets market, 2021 - 2033 (USD Million)
  • Fig. 23 Creams market, 2021 - 2033 (USD Million)
  • Fig. 24 Gels market, 2021 - 2033 (USD Million)
  • Fig. 25 Others market, 2021 - 2033 (USD Million)
  • Fig. 26 Laser products market, 2021 - 2033 (USD Million)
  • Fig. 27 Pulsed dye lasers market, 2021 - 2033 (USD Million)
  • Fig. 28 CO2 lasers market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 Injectables market, 2021 - 2033 (USD Million)
  • Fig. 31 Hypertrophic & keloid scar treatment market: End use segment dashboard
  • Fig. 32 Hypertrophic & keloid scar treatment market: End use market share analysis, 2025 & 2033
  • Fig. 33 Business-to-business (B2B) market, 2021 - 2033 (USD Million)
  • Fig. 34 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 35 Clinics market, 2021 - 2033 (USD Million)
  • Fig. 36 Business to consumers (B2C) market, 2021 - 2033 (USD Million)
  • Fig. 37 Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 38 Online/e-commerce market, 2021 - 2033 (USD Million)
  • Fig. 39 Hypermarkets & supermarkets market, 2021 - 2033 (USD Million)
  • Fig. 40 Others market, 2021 - 2033 (USD Million)
  • Fig. 41 Global hypertrophic & keloid scar treatment market: Regional movement analysis
  • Fig. 42 Global hypertrophic & keloid scar treatment market: Regional outlook and key takeaways
  • Fig. 43 Global hypertrophic & keloid scar treatment market share and leading players
  • Fig. 44 North America, by country
  • Fig. 45 North America
  • Fig. 46 North America market estimates and forecasts, 2021 - 2033
  • Fig. 47 U.S.
  • Fig. 48 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 49 Canada
  • Fig. 50 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 51 Mexico
  • Fig. 52 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 53 Europe
  • Fig. 54 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 55 UK
  • Fig. 56 UK market estimates and forecasts, 2021 - 2033
  • Fig. 57 Germany
  • Fig. 58 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 59 France
  • Fig. 60 France market estimates and forecasts, 2021 - 2033
  • Fig. 61 Italy
  • Fig. 62 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 63 Spain
  • Fig. 64 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 65 Denmark
  • Fig. 66 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 67 Sweden
  • Fig. 68 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 69 Norway
  • Fig. 70 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 71 Asia Pacific
  • Fig. 72 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 73 China
  • Fig. 74 China market estimates and forecasts, 2021 - 2033
  • Fig. 75 Japan
  • Fig. 76 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 77 India
  • Fig. 78 India market estimates and forecasts, 2021 - 2033
  • Fig. 79 Australia
  • Fig. 80 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 81 South Korea
  • Fig. 82 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 83 Thailand
  • Fig. 84 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 85 Latin America
  • Fig. 86 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 87 Brazil
  • Fig. 88 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 89 Argentina
  • Fig. 90 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 91 Middle East and Africa
  • Fig. 92 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 93 South Africa
  • Fig. 94 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 95 Saudi Arabia
  • Fig. 96 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 97 UAE
  • Fig. 98 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 99 Kuwait
  • Fig. 100 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 101 Market share of key market players- Hypertrophic & keloid scar treatment market